Endoproteolytic activity of the proteasome.

Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem (2009) 8.83

Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J Cell Biol (2003) 4.35

The recognition and retrotranslocation of misfolded proteins from the endoplasmic reticulum. Traffic (2008) 3.07

Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J (2004) 3.01

Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein. J Neurosci (2011) 2.53

Classification of intrinsically disordered regions and proteins. Chem Rev (2014) 2.48

Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proc Natl Acad Sci U S A (2005) 2.45

Dissecting the ER-associated degradation of a misfolded polytopic membrane protein. Cell (2008) 2.41

APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol Cell (2007) 2.35

ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome. Mol Cell (2006) 2.26

Targeting proteins for degradation. Nat Chem Biol (2009) 2.22

N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev (2004) 2.14

Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol Cell Biol (2006) 1.89

The proteasome: overview of structure and functions. Proc Jpn Acad Ser B Phys Biol Sci (2009) 1.82

The otubain YOD1 is a deubiquitinating enzyme that associates with p97 to facilitate protein dislocation from the ER. Mol Cell (2009) 1.82

Multisite protein kinase A and glycogen synthase kinase 3beta phosphorylation leads to Gli3 ubiquitination by SCFbetaTrCP. Mol Cell Biol (2006) 1.82

Ubiquitin and proteasomes in transcription. Annu Rev Biochem (2012) 1.67

The cytoplasmic Hsp70 chaperone machinery subjects misfolded and endoplasmic reticulum import-incompetent proteins to degradation via the ubiquitin-proteasome system. Mol Biol Cell (2006) 1.61

Ubiquitin-independent degradation of antiapoptotic MCL-1. Mol Cell Biol (2010) 1.54

Proteasome substrate degradation requires association plus extended peptide. EMBO J (2006) 1.54

FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol Cell Biol (2005) 1.53

Aging perturbs 26S proteasome assembly in Drosophila melanogaster. FASEB J (2007) 1.49

Acyldepsipeptide antibiotics induce the formation of a structured axial channel in ClpP: A model for the ClpX/ClpA-bound state of ClpP. Chem Biol (2010) 1.48

Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination. J Mol Biol (2009) 1.43

Structural biology of the proteasome. Annu Rev Biophys (2013) 1.42

N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol Cell Biol (2004) 1.40

The cochaperone BAG2 sweeps paired helical filament- insoluble tau from the microtubule. J Neurosci (2009) 1.38

Pre-folding IkappaBalpha alters control of NF-kappaB signaling. J Mol Biol (2008) 1.35

The proteasome antechamber maintains substrates in an unfolded state. Nature (2010) 1.34

Glycine-alanine repeats impair proper substrate unfolding by the proteasome. EMBO J (2006) 1.34

MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2. Mol Cell Biol (2007) 1.33

Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med (2015) 1.29

Aging and regulated protein degradation: who has the UPPer hand? Aging Cell (2007) 1.27

The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner. EMBO J (2006) 1.27

Proteasome-mediated cleavage of the Y-box-binding protein 1 is linked to DNA-damage stress response. EMBO J (2005) 1.23

Ubiquilin regulates presenilin endoproteolysis and modulates gamma-secretase components, Pen-2 and nicastrin. Biochem J (2005) 1.14

Protein targeting to ATP-dependent proteases. Curr Opin Struct Biol (2008) 1.14

α-Synuclein fate is determined by USP9X-regulated monoubiquitination. Proc Natl Acad Sci U S A (2011) 1.13

The RNA exosome and proteasome: common principles of degradation control. Nat Rev Mol Cell Biol (2013) 1.12

A tetrahedral transition state at the active sites of the 20S proteasome is coupled to opening of the alpha-ring channel. Structure (2009) 1.11

Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs). Chem Rev (2014) 1.10

Gly-Ala repeats induce position- and substrate-specific regulation of 26 S proteasome-dependent partial processing. J Biol Chem (2008) 1.08

Disruption of protein quality control in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 1.07

Protein degradation pathways in Parkinson's disease: curse or blessing. Acta Neuropathol (2012) 1.07

Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner. J Biol Chem (2010) 1.07

Degradation of damaged proteins: the main function of the 20S proteasome. Prog Mol Biol Transl Sci (2012) 1.07

Ubiquitin-independent degradation of hepatitis C virus F protein. J Virol (2008) 1.06

Slippery substrates impair ATP-dependent protease function by slowing unfolding. J Biol Chem (2013) 1.06

14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer. Mol Cell Biol (2010) 1.06

A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease. Biochim Biophys Acta (2009) 1.02

Intrinsically disordered segments affect protein half-life in the cell and during evolution. Cell Rep (2014) 1.01

Structure and function of a novel type of ATP-dependent Clp protease. J Biol Chem (2009) 1.00

Susceptibility of p53 unstructured N terminus to 20 S proteasomal degradation programs the stress response. J Biol Chem (2009) 0.97

The C terminus of Rpt3, an ATPase subunit of PA700 (19 S) regulatory complex, is essential for 26 S proteasome assembly but not for activation. J Biol Chem (2010) 0.96

Degradation of some polyubiquitinated proteins requires an intrinsic proteasomal binding element in the substrates. J Biol Chem (2009) 0.96

Hzf, a p53-responsive gene, regulates maintenance of the G2 phase checkpoint induced by DNA damage. Mol Cell Biol (2006) 0.95

Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease. J Parkinsons Dis (2015) 0.93

Two-substrate association with the 20S proteasome at single-molecule level. EMBO J (2004) 0.92

The protein level of PGC-1α, a key metabolic regulator, is controlled by NADH-NQO1. Mol Cell Biol (2013) 0.92

A cellular model to monitor proteasome dysfunction by alpha-synuclein. Biochemistry (2009) 0.91

Protein disulfide isomerases contribute differentially to the endoplasmic reticulum-associated degradation of apolipoprotein B and other substrates. Mol Biol Cell (2011) 0.90

N-glycosylation enhances presentation of a MHC class I-restricted epitope from tyrosinase. J Immunol (2009) 0.90

Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model. J Neurosci (2012) 0.89

Neonatal hyperoxia stimulates the expansion of alveolar epithelial type II cells. Am J Respir Cell Mol Biol (2014) 0.88

Site-specific methionine oxidation initiates calmodulin degradation by the 20S proteasome. Biochemistry (2009) 0.88

Redox control of 20S proteasome gating. Antioxid Redox Signal (2012) 0.88

Multiple sclerosis autoantigen myelin basic protein escapes control by ubiquitination during proteasomal degradation. J Biol Chem (2014) 0.88

A mathematical model of protein degradation by the proteasome. Biophys J (2005) 0.87

Disordered proteinaceous machines. Chem Rev (2014) 0.86

The archaeal proteasome is regulated by a network of AAA ATPases. J Biol Chem (2012) 0.86

Proteasomal degradation from internal sites favors partial proteolysis via remote domain stabilization. ACS Chem Biol (2011) 0.85

Rapid proteasomal degradation of posttranscriptional regulators of the TIS11/tristetraprolin family is induced by an intrinsically unstructured region independently of ubiquitination. Mol Cell Biol (2014) 0.84

Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations. J Bioenerg Biomembr (2010) 0.84

The Interplay between Alpha-Synuclein Clearance and Spreading. Biomolecules (2015) 0.84

Redox regulation of the proteasome via S-glutathionylation. Redox Biol (2013) 0.84

Context-dependent resistance to proteolysis of intrinsically disordered proteins. Protein Sci (2011) 0.84

Direct ubiquitin independent recognition and degradation of a folded protein by the eukaryotic proteasomes-origin of intrinsic degradation signals. PLoS One (2012) 0.83

Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology. Am J Pathol (2010) 0.83

Effects of stability on the biological function of p53. J Biol Chem (2009) 0.82

LYL1 degradation by the proteasome is directed by a N-terminal PEST rich site in a phosphorylation-independent manner. PLoS One (2010) 0.81

Open-gate mutants of the mammalian proteasome show enhanced ubiquitin-conjugate degradation. Nat Commun (2016) 0.80

Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system. Biochim Biophys Acta (2008) 0.80

Plastidial starch phosphorylase in sweet potato roots is proteolytically modified by protein-protein interaction with the 20S proteasome. PLoS One (2012) 0.80

14-3-3Gamma inhibition of MDMX-mediated p21 turnover independent of p53. J Biol Chem (2010) 0.79

Phosphorylation regulates the ubiquitin-independent degradation of yeast Pah1 phosphatidate phosphatase by the 20S proteasome. J Biol Chem (2015) 0.79

Nuclear transport of yeast proteasomes. Biomolecules (2014) 0.79

An archaeal homolog of proteasome assembly factor functions as a proteasome activator. PLoS One (2013) 0.78

PaCS is a novel cytoplasmic structure containing functional proteasome and inducible by cytokines/trophic factors. PLoS One (2013) 0.78

Sirtuins and proteolytic systems: implications for pathogenesis of synucleinopathies. Biomolecules (2015) 0.78

Particle-rich cytoplasmic structure (PaCS): identification, natural history, role in cell biology and pathology. Biomolecules (2014) 0.77

N-terminal α7 deletion of the proteasome 20S core particle substitutes for yeast PI31 function. Mol Cell Biol (2014) 0.76

Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4/RIL protein. J Biol Chem (2011) 0.76

Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease. PLoS One (2016) 0.76

The Proteasome Inhibition Model of Parkinson's disease. J Parkinsons Dis (2016) 0.76

Ubiquitin proteasomal pathway mediated degradation of p53 in melanoma. Arch Biochem Biophys (2010) 0.76

Harnessing proteasome dynamics and allostery in drug design. Antioxid Redox Signal (2014) 0.75

Establishment of a suite of assays that support the discovery of proteasome stimulators. Biochim Biophys Acta (2017) 0.75

Force spectroscopy of substrate molecules en route to the proteasome's active sites. Biophys J (2011) 0.75

AAA-ATPases in Protein Degradation. Front Mol Biosci (2017) 0.75

Proteasomal activities in the claw muscle tissue of European lobster, Homarus gammarus, during larval development. J Comp Physiol B (2011) 0.75

The ubiquitin system. Annu Rev Biochem (1998) 43.36

Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science (1995) 12.94

The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem (1999) 8.97

Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science (2002) 7.49

NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry (1996) 6.47

A cryptic protease couples deubiquitination and degradation by the proteasome. Nature (2002) 6.21

A gated channel into the proteasome core particle. Nat Struct Biol (2000) 5.42

A 26 S protease subunit that binds ubiquitin conjugates. J Biol Chem (1994) 4.93

Splitting the chromosome: cutting the ties that bind sister chromatids. Science (2000) 4.20

Activation of a membrane-bound transcription factor by regulated ubiquitin/proteasome-dependent processing. Cell (2000) 3.97

Reversible denaturation of Aequorea green-fluorescent protein: physical separation and characterization of the renatured protein. Biochemistry (1982) 3.72

Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell (2001) 3.62

The structure of the mammalian 20S proteasome at 2.75 A resolution. Structure (2002) 3.44

Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell (2000) 3.42

Structural basis for the activation of 20S proteasomes by 11S regulators. Nature (2000) 3.04

The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release. Mol Cell (2001) 2.91

A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal. Nature (2002) 2.86

The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem (1999) 2.72

The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat Cell Biol (1999) 2.22

Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell (1998) 2.21

Identification, purification, and characterization of a high molecular weight, ATP-dependent activator (PA700) of the 20 S proteasome. J Biol Chem (1994) 2.15

alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett (2001) 1.87

Proteins are unfolded on the surface of the ATPase ring before transport into the proteasome. Mol Cell (2001) 1.81

Protein splicing of inteins and hedgehog autoproteolysis: structure, function, and evolution. Cell (1998) 1.63

Conformational constraints in protein degradation by the 20S proteasome. Nat Struct Biol (1995) 1.42

Recognition of misfolding proteins by PA700, the regulatory subcomplex of the 26 S proteasome. J Biol Chem (2000) 1.32

The cyclization and polymerization of bacterially expressed proteins using modified self-splicing inteins. J Biol Chem (1999) 1.31

The high molecular weight multicatalytic proteinase, macropain, exists in a latent form in human erythrocytes. Biochim Biophys Acta (1989) 1.24

Conformational remodeling of proteasomal substrates by PA700, the 19 S regulatory complex of the 26 S proteasome. J Biol Chem (2002) 1.15

Concurrent translocation of multiple polypeptide chains through the proteasomal degradation channel. J Biol Chem (2002) 1.13

ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol Cell (2002) 4.79

Disruption of the basal body compromises proteasomal function and perturbs intracellular Wnt response. Nat Genet (2007) 4.24

Gating of CFTR by the STAS domain of SLC26 transporters. Nat Cell Biol (2004) 3.43

Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J (2003) 3.35

Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1. Nat Cell Biol (2006) 3.14

Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet (2013) 2.91

Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol (2009) 2.70

Cooperative, ATP-dependent association of the nucleotide binding cassettes during the catalytic cycle of ATP-binding cassette transporters. J Biol Chem (2002) 2.64

Side chain and backbone contributions of Phe508 to CFTR folding. Nat Struct Mol Biol (2004) 2.43

Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome. Mol Biol Cell (2007) 2.28

ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome. Mol Cell (2006) 2.26

RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis. J Cell Sci (2003) 2.21

A molecular mechanism for aberrant CFTR-dependent HCO(3)(-) transport in cystic fibrosis. EMBO J (2002) 2.11

Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells. Mol Biol Cell (2006) 2.07

PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet (2010) 2.05

CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices. Nat Struct Mol Biol (2007) 1.98

Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation. Chem Biol (2008) 1.97

Differential roles of the COOH termini of AAA subunits of PA700 (19 S regulator) in asymmetric assembly and activation of the 26 S proteasome. J Biol Chem (2008) 1.93

Intracellular localization of proteasomes. Int J Biochem Cell Biol (2003) 1.92

A protein sequence that can encode native structure by disfavoring alternate conformations. Nat Struct Biol (2002) 1.85

Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences. Cell (2012) 1.81

Coupling modes and stoichiometry of Cl-/HCO3- exchange by slc26a3 and slc26a6. J Gen Physiol (2006) 1.73

A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. J Biol Chem (2005) 1.65

Slc26a6 regulates CFTR activity in vivo to determine pancreatic duct HCO3- secretion: relevance to cystic fibrosis. EMBO J (2006) 1.56

Regulation of the proteasome by neuronal activity and calcium/calmodulin-dependent protein kinase II. J Biol Chem (2009) 1.55

The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis. J Biol Chem (2010) 1.55

Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95. Cell (2012) 1.48

Analysis of Drosophila 26 S proteasome using RNA interference. J Biol Chem (2001) 1.46

Real-time fluorescence detection of ERAD substrate retrotranslocation in a mammalian in vitro system. Cell (2007) 1.44

Congenital chloride-losing diarrhea causing mutations in the STAS domain result in misfolding and mistrafficking of SLC26A3. J Biol Chem (2008) 1.43

Lewy-body formation is an aggresome-related process: a hypothesis. Lancet Neurol (2004) 1.41

Subcomplexes of PA700, the 19 S regulator of the 26 S proteasome, reveal relative roles of AAA subunits in 26 S proteasome assembly and activation and ATPase activity. J Biol Chem (2009) 1.38

Uncoupling retro-translocation and degradation in the ER-associated degradation of a soluble protein. EMBO J (2004) 1.38

Dynamic control of cystic fibrosis transmembrane conductance regulator Cl(-)/HCO3(-) selectivity by external Cl(-). J Biol Chem (2004) 1.28

The torsin-family AAA+ protein OOC-5 contains a critical disulfide adjacent to Sensor-II that couples redox state to nucleotide binding. Mol Biol Cell (2008) 1.25

Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator. J Biol Chem (2003) 1.23

IRBIT governs epithelial secretion in mice by antagonizing the WNK/SPAK kinase pathway. J Clin Invest (2011) 1.18

Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening. J Comput Aided Mol Des (2010) 1.17

The primary folding defect and rescue of ΔF508 CFTR emerge during translation of the mutant domain. PLoS One (2010) 1.17

Conformational remodeling of proteasomal substrates by PA700, the 19 S regulatory complex of the 26 S proteasome. J Biol Chem (2002) 1.15

Building an understanding of cystic fibrosis on the foundation of ABC transporter structures. J Bioenerg Biomembr (2007) 1.14

NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR. EMBO J (2009) 1.12

Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes. J Neurochem (2003) 1.12

Regulatory R region of the CFTR chloride channel is a dynamic integrator of phospho-dependent intra- and intermolecular interactions. Proc Natl Acad Sci U S A (2013) 1.06

Aggresome formation. Methods Mol Biol (2005) 1.06

The cystic fibrosis transmembrane conductance regulator interacts with and regulates the activity of the HCO3- salvage transporter human Na+-HCO3- cotransport isoform 3. J Biol Chem (2002) 1.06

Regulatory interaction between CFTR and the SLC26 transporters. Novartis Found Symp (2006) 1.04

A unique redox-sensing sensor II motif in TorsinA plays a critical role in nucleotide and partner binding. J Biol Chem (2010) 1.04

C termini of proteasomal ATPases play nonequivalent roles in cellular assembly of mammalian 26 S proteasome. J Biol Chem (2011) 1.01

ATP binding by proteasomal ATPases regulates cellular assembly and substrate-induced functions of the 26 S proteasome. J Biol Chem (2012) 1.00

The C terminus of Rpt3, an ATPase subunit of PA700 (19 S) regulatory complex, is essential for 26 S proteasome assembly but not for activation. J Biol Chem (2010) 0.96

Nucleotide binding domain interactions during the mechanochemical reaction cycle of ATP-binding cassette transporters. J Bioenerg Biomembr (2005) 0.93

Mutations that change the position of the putative gamma-phosphate linker in the nucleotide binding domains of CFTR alter channel gating. J Biol Chem (2002) 0.91

JAMP optimizes ERAD to protect cells from unfolded proteins. Mol Biol Cell (2008) 0.88

Recognition and processing of misfolded proteins by PA700, the 19S regulatory complex of the 26S proteasome. Methods Mol Biol (2005) 0.87

Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations. J Bioenerg Biomembr (2010) 0.84

Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology. Am J Pathol (2010) 0.83

Alteration of CFTR transmembrane span integration by disease-causing mutations. Mol Biol Cell (2011) 0.82

Modulation of gene expression by RNAi. Methods Mol Med (2005) 0.81

Assessment of protein folding/solubility in live cells. Methods Mol Biol (2003) 0.80

CFTR Folding Consortium: methods available for studies of CFTR folding and correction. Methods Mol Biol (2011) 0.79

The BiP molecular chaperone plays multiple roles during the biogenesis of torsinA, an AAA+ ATPase associated with the neurological disease early-onset torsion dystonia. J Biol Chem (2014) 0.79

Biochemical and biophysical approaches to probe CFTR structure. Methods Mol Biol (2011) 0.78

TDP-43 identified from a genome wide RNAi screen for SOD1 regulators. PLoS One (2012) 0.78

Development of CFTR Structure. Front Pharmacol (2012) 0.77

Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HT-mediated human cavernosal contraction. J Androl (2006) 0.77

Introduction to section IV: biophysical methods to approach CFTR structure. Methods Mol Biol (2011) 0.76

A screen to identify cellular modulators of soluble levels of an amyotrophic lateral sclerosis (ALS)-causing mutant SOD1. J Biomol Screen (2011) 0.76

CFTR degradation and aggregation. Methods Mol Med (2002) 0.76

In vitro CFTR folding assays. Methods Mol Med (2002) 0.75